MedTrace Logo

Nerveblocks for Persistent Pain After Breast Cancer Surgery

NCT02336529 · Status: UNKNOWN · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 48

Last updated 2015-10-27

No results posted yet for this study

Summary

Persistent pain after breast cancer surgery (PPBCS) affects 25-60% of breast cancer survivors and nerve damage has been implicated as the cause of this neuropathic pain condition. Local anaesthetic blockade of tenderpoints and the intercostobrachial nerve (ICBN) could provide clues to pathophysiological mechanisms as well as aiding diagnosis and treatment of PPBCS but has never been attempted. The aims of this study is to examine clinical effect of ultrasound guided blockades of the ICBN and tenderpoints of pain.

Conditions

Interventions

DRUG

Bupivacaine

DRUG

NaCl

Sponsors & Collaborators

  • Kenneth Geving Andersen

    lead OTHER

Principal Investigators

  • Nelun Wijayasinghe, MD · Rigshospitalet, University of Copenhagen

  • Kenneth G Andersen, MD, PhD · Rigshospitalet, University of Copenhagen

Study Design

Allocation
RANDOMIZED
Purpose
DIAGNOSTIC
Masking
TRIPLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-07-31
Primary Completion
2017-07-31
Completion
2017-07-31

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02336529 on ClinicalTrials.gov